IL162098A0 - Combination of a selective pde4 inhibor and an adrenergic beta-2 receptor agonist - Google Patents

Combination of a selective pde4 inhibor and an adrenergic beta-2 receptor agonist

Info

Publication number
IL162098A0
IL162098A0 IL16209802A IL16209802A IL162098A0 IL 162098 A0 IL162098 A0 IL 162098A0 IL 16209802 A IL16209802 A IL 16209802A IL 16209802 A IL16209802 A IL 16209802A IL 162098 A0 IL162098 A0 IL 162098A0
Authority
IL
Israel
Prior art keywords
inhibor
combination
receptor agonist
adrenergic beta
selective pde4
Prior art date
Application number
IL16209802A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL162098A0 publication Critical patent/IL162098A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
IL16209802A 2001-12-07 2002-11-22 Combination of a selective pde4 inhibor and an adrenergic beta-2 receptor agonist IL162098A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0129395.0A GB0129395D0 (en) 2001-12-07 2001-12-07 Pharmaceutical combination
PCT/IB2002/004922 WO2003047578A1 (en) 2001-12-07 2002-11-22 Combination of a selective pde4 inhibitor and an adrenergic beta-2 receptor agonist

Publications (1)

Publication Number Publication Date
IL162098A0 true IL162098A0 (en) 2005-11-20

Family

ID=9927247

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16209802A IL162098A0 (en) 2001-12-07 2002-11-22 Combination of a selective pde4 inhibor and an adrenergic beta-2 receptor agonist

Country Status (33)

Country Link
US (2) US20030119862A1 (xx)
EP (1) EP1455783A1 (xx)
JP (1) JP2005511657A (xx)
KR (1) KR20050044699A (xx)
CN (1) CN1599609A (xx)
AP (1) AP2004003054A0 (xx)
AR (1) AR037712A1 (xx)
AU (1) AU2002353255A1 (xx)
BR (1) BR0214776A (xx)
CA (1) CA2468676A1 (xx)
CO (1) CO5590899A2 (xx)
EA (1) EA200400640A1 (xx)
EC (1) ECSP045142A (xx)
GB (1) GB0129395D0 (xx)
HN (1) HN2002000356A (xx)
HR (1) HRP20040515A2 (xx)
HU (1) HUP0402546A3 (xx)
IL (1) IL162098A0 (xx)
IS (1) IS7277A (xx)
MA (1) MA27152A1 (xx)
MX (1) MXPA04004930A (xx)
NO (1) NO20042870L (xx)
NZ (1) NZ533030A (xx)
OA (1) OA12736A (xx)
PA (1) PA8560601A1 (xx)
PE (1) PE20031066A1 (xx)
PL (1) PL370770A1 (xx)
SV (1) SV2004001430A (xx)
TN (1) TNSN04102A1 (xx)
TW (1) TWI242433B (xx)
UY (1) UY27564A1 (xx)
WO (1) WO2003047578A1 (xx)
ZA (1) ZA200403905B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
TWI359675B (en) * 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
DE10360954B3 (de) * 2003-12-23 2005-08-18 Esparma Gmbh Verwendung von Silibinin, dessen Salzen und/oder dessen Prodrugs zusammen mit α-Liponsäure zur Behandlung chronisch obstruktiver Lungenerkrankungen
WO2012098495A1 (en) * 2011-01-19 2012-07-26 Glenmark Pharmaceuticals Sa Pharmaceutical composition that includes revamilast and a beta-2 agonist

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0837860T3 (da) * 1995-06-06 2002-05-27 Pfizer Tricykliske 5,6-dihydro-9H-pyrazolo[3,4-c]-1,2,4-triazolo-[4,3-alfa]pyridiner
BR9913152A (pt) * 1998-08-26 2001-05-15 Smithkline Beecham Corp Terapias para tratamento de doenças pulmonares
KR100701904B1 (ko) * 1999-08-21 2007-04-02 알타나 파마 아게 Ｐｄｅ 억제제 및 베타 2 아드레날린수용체 작동제의상승적 조합

Also Published As

Publication number Publication date
SV2004001430A (es) 2004-02-24
OA12736A (en) 2006-06-29
GB0129395D0 (en) 2002-01-30
HRP20040515A2 (en) 2004-10-31
ZA200403905B (en) 2005-06-22
CO5590899A2 (es) 2005-12-30
HN2002000356A (es) 2003-02-21
WO2003047578A1 (en) 2003-06-12
TWI242433B (en) 2005-11-01
CN1599609A (zh) 2005-03-23
AR037712A1 (es) 2004-12-01
EA200400640A1 (ru) 2004-12-30
EP1455783A1 (en) 2004-09-15
TNSN04102A1 (fr) 2006-06-01
CA2468676A1 (en) 2003-06-12
NZ533030A (en) 2007-03-30
UY27564A1 (es) 2003-07-31
PA8560601A1 (es) 2005-02-04
AU2002353255A1 (en) 2003-06-17
HUP0402546A2 (hu) 2005-04-28
US20040167153A1 (en) 2004-08-26
KR20050044699A (ko) 2005-05-12
ECSP045142A (es) 2004-07-23
PL370770A1 (en) 2005-05-30
MA27152A1 (fr) 2005-01-03
BR0214776A (pt) 2004-11-09
JP2005511657A (ja) 2005-04-28
TW200300678A (en) 2003-06-16
AP2004003054A0 (en) 2004-06-30
IS7277A (is) 2004-05-21
HUP0402546A3 (en) 2008-04-28
PE20031066A1 (es) 2003-12-24
US20030119862A1 (en) 2003-06-26
MXPA04004930A (es) 2005-04-08
NO20042870L (no) 2004-07-06

Similar Documents

Publication Publication Date Title
EP1450513A4 (en) COMMUNICATION DEVICE AND METHOD
EP1458137A4 (en) COMMUNICATION DEVICE AND METHOD
PL367025A1 (en) Mixed metallocene catalyst systems containing a poor comonomer incorporator and a good comonomer incorporator
EP1450694A4 (en) CUTTING AND CRIMPING DEVICE
IL161329A0 (en) Benzamide and heteroarylamide as p2x7 receptor antagonists
EP1368863A4 (en) FASTENING DEVICE AND METHOD
ATE430124T1 (de) Arylanilin beta-2 adrenergische rezeptor agoniste
HUP0103993A3 (en) Ecdysone receptors and methods for their use
AU4552099A (en) Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5HT2 receptors
AU2002314433A1 (en) Ephrin-tie receptor materials and methods
GB0224218D0 (en) A selective catalytic reduction device and methods for use therein
EP1455182A4 (en) FAILURE EVALUATION METHOD AND ANALYZER
AU2002361742A1 (en) Parental analgesic formulations comprising fentanyl and a cannabinoid receptor agonist
GB0215777D0 (en) Method and device for monitoring the performance of a network
EP1389513A4 (en) DRILLING AND DRILLING
GB2371954B (en) Interface system for wireless node and network node
EP1453503A4 (en) EP4 RECEPTOR AGONIST, COMPOSITIONS AND METHODS
HK1154504A1 (en) Chemokine receptor antagonists and methods of use thereof
EP1257075A4 (en) SENDING DEVICE AND SENDING METHOD
IL138576A0 (en) A novel interleukin-1 receptor antagonist and uses thereof
AU2002254076A1 (en) Chemokine receptors and disease
IL162098A0 (en) Combination of a selective pde4 inhibor and an adrenergic beta-2 receptor agonist
AU9275001A (en) Notch receptor agonists and uses
AU2002347532A1 (en) Combination of an adenosine a2a receptor agonist and an adrenergic beta-2 receptor agonist
PL373275A1 (en) Ccr-3 receptor antagonists vii